Reports

Featured reports

Latest reports

National cancer screening programs participation data 

Cancer screening programs aim to reduce illness and death from selected cancers. This report presents the latest cancer screening participation rates and trends for Australia’s 3 national cancer screening programs. Participation rates are presented for Australia, states and territories, the 31 Primary Health Network areas, and for more than 300 smaller local areas (SA2s and SA3s) across Australia. Data can be explored as data visualisations or Excel data files.

Cervical screening in Australia 2019 

This is the last monitoring report (to 30 June 2017) for the previous ‘Pap test-based’ National Cervical Screening Program, which ceased on 30 November 2017. For women aged 20–69, participation was estimated at 54%–56%, 7 out of every 1,000 women screened had a high-grade abnormality detected before possible progression to cervical cancer, there were 9–10 new cases per 100,000 women, and there were 2 deaths per 100,000 women.

Cancer in Australia 2019: in brief 

In 2019, the rate of new cancer cases in Australia is expected to reach 483 new cases per 100,000 people, while cancer-related deaths are expected to decrease to 159 per 100,000 people. From 1982 to 2019, thyroid cancer and liver cancer incidence rates increased more than for any other cancer. Although liver cancer survival has improved since 1982, with the increasing liver cancer incidence rate, liver cancer mortality rates also increased more than those for any other cancer. 

Analysis of breast cancer outcomes and screening behaviour for BreastScreen Australia 

This is the second report from an Australian-first project combining data from BreastScreen Australia, the National Cervical Screening Program and the National Bowel Cancer Screening Program, focusing on breast cancer outcomes and screening behaviour in BreastScreen Australia. It was found that screen-detected breast cancers were less likely to cause death than never-screened breast cancers for all age groups eligible to screen in BreastScreen Australia, with analyses giving new insights into screening behaviour.

Mesothelioma in Australia 2017 

Mesothelioma in Australia – infocus presents the latest available information on the incidence of mesothelioma in Australia, along with mortality and information on previous asbestos exposure, using data from the Australian Mesothelioma Registry (AMR), the National Mortality Database (NMD) and the Australian Cancer Database (ACD). On average, two people are diagnosed with mesothelioma in Australia each day.

Colorectal and other digestive-tract cancers 

Digestive-tract cancers are estimated to account for about 2 in 10 of all cancers diagnosed and nearly 3 in 10 cancer deaths. A person’s chance of surviving depends on the type of digestive-tract cancer: colorectal cancer (the most common digestive-tract cancer) had the highest 5-year relative survival rate (69%), while pancreatic cancer (the second most common digestive-tract cancer) had the lowest 5-year relative survival of all specified digestive cancers (8.7%). 

BreastScreen Australia monitoring report 2018 

Around 55% of women in the targeted age group of 50–74 participated in the BreastScreen Australia in 2015–2016 with more than 1.7 million screening. Breast cancer mortality has decreased since BreastScreen Australia began from 74 deaths per 100,000 women aged 50–74 in 1991 to 44 deaths per 100,000 women in 2015.
 

Analysis of cancer outcomes and screening behaviour for national cancer screening programs in Australia 

This is the first report from an Australian-first project combining data from the National Bowel Cancer Screening Program, BreastScreen Australia, and the National Cervical Screening Program. It was found that screen-detected breast, cervical and bowel cancers were less likely to cause death than non-screen-detected cancers, with analyses also revealing novel patterns in screening behaviour.

Radiotherapy in Australia 2016–17 

In 2016–17, over 63,500 courses of radiotherapy were delivered in Australia. 50% of all radiotherapy patients started treatment within 9 days, and 90% within 26 days. For those who needed emergency treatment (1.5% of courses), almost 95% began treatment within the recommended timeframe—on the same or the next day.

Incidence of selected cancers in 2009–2013 

This report on local cancer incidence rates (newly diagnosed cases) are available for all cancers combined, as well as breast, cervical, prostate, colorectal, lung and melanoma of the skin. Results are presented by the 31 Primary Health Network areas and for more than 300 smaller local areas (SA3s) across Australia.

This report was first published on the MyHealthyCommunities website.

Cancer in adolescents and young adults in Australia 

This report is the second national report to present key data specific to cancer in adolescents and young adults. While cancer in young Australians is rare, it has a substantial social and economic impact on individuals, families and the community. Surveillance of this population is also important as adolescent and young adult cancer survivors are at an increased risk of developing a second cancer. 
 

Cancer in Aboriginal & Torres Strait Islander people of Australia 

Cancer in Aboriginal and Torres Strait Islander people of Australia presents the latest available information on national population screening programs, cancer incidence, survival, prevalence and mortality for Aboriginal and Torres Strait Islander Australians, compared with non-Indigenous Australians. Information is available as data visualisations to explore by sex, age, state and territory, remoteness area and trend.

Cancer incidence and mortality in Australia by small geographic areas 

These tables present the latest cancer incidence and mortality data in Australia by Primary Health Network (PHN) and Statistical Area Level 3 (SA3) for all cancers combined, and six selected cancers (female breast cancer, colorectal cancer, cervical cancer, lung cancer, melanoma of the skin, and prostate cancer).

Brain and other central nervous system cancers 

This report is the first national report to present key data specific to brain and other central nervous system (CNS) cancer. While brain and other CNS cancer is rare, it has a substantial social and economic impact on individuals, families and community. Non malignant brain and other CNS tumours also cause significant morbidity and mortality.

Radiotherapy in Australia 2015–16 

In 2015–16, 60,600 courses of radiotherapy were delivered in Australia. For non-emergency treatment, 50% of patients started treatment within 9 days, and 90% within 27 days. For those who needed emergency treatment, 91% began treatment within the emergency timeframe. Data covered effectively 100% of courses delivered in Australia.

Burden of cancer in Australia: Australian Burden of Disease Study 2011 

Cancer was the greatest cause of health burden in Australia in 2011, accounting for around one-fifth of the total disease burden. Most (94%) of this burden was due to dying prematurely, with only a small proportion of the burden due to living with a cancer diagnosis. This report explores in further detail the burden of cancer in Australia, including cancer burden in Aboriginal and Torres Strait islander people, and by remoteness and socioeconomic group. It also looks at how the cancer burden has changed since 2003, and the potential burden of cancer expected in 2020.

National Cervical Screening Program Data Dictionary version 1.0 

The National Cervical Screening Program aims to reduce incidence, morbidity and mortality from cervical cancer in Australia. A new National Cervical Screening Program is scheduled to commence on 1 December 2017—this new National Cervical Screening Program data dictionary is a key document that has been developed by the Australian Institute of Health and Welfare with the assistance of state and territory cervical screening programs and other cervical screening experts, to support monitoring and reporting by the Australian Institute of Health and Welfare for the new National Cervical Screening Program.

National Bowel Cancer Screening Program: monitoring report 2017 

This report presents statistics on the National Bowel Cancer Screening Program (NBCSP) using key performance indicators. Of those who were invited to participate in the NBCSP between 1 January 2014 and 31 December 2015, 39% undertook screening. For those screened in 2015, 8% had a positive result warranting further assessment. One in 29 participants who underwent a follow-up diagnostic assessment was diagnosed with a confirmed or suspected cancer.

Cervical screening in Australia 2014–2015 

Cervical screening in Australia 2014–2015 presents the latest national statistics monitoring the National Cervical Screening Program, which aims to reduce incidence, morbidity and mortality from cervical cancer. Just over half (56%) of women in the target age group of 20–69 took part in the program, with more than 3.8 million women screening in 2014 and 2015. Cervical cancer incidence for women of all ages remains at an historical low of 7 new cases per 100,000 women, and deaths are also low, historically and by international standards, at 2 deaths per 100,000 women.

Cancer in Australia 2017  

Cancer in Australia 2017 presents the latest available information on national population screening programs, Medicare data, cancer incidence, hospitalisations, survival, prevalence, mortality and burden of disease. Cancer is the leading cause of disease burden in Australia.